Pilot study comparing two emollients, Emulsifying ointment B.P. and Epaderm topical ointment in children with eczema

Capital and Coast District Health board0 个研究点目标入组 60 人开始时间: 2015年12月9日最近更新: 2020年1月13日

试验速览

暂无简介。

•a) Eczema with a severity on SCORAD of greater or equal to 5 for objective measures only
•b) Children with eczema aged 0-5
•c) Parent/caregiver must be able to speak enough English to understand the trial and be able to complete the trial diary

•a) Other serious chronic disease that may require immunosuppressive therapy, as decided on a case by case basis by the principal investigator.
•b) Use of systemic antibacterial therapy within one week prior to starting study treatment
•c) Patients with co-morbid conditions that would require long term systemic corticosteroid therapy during study treatment. Systemic steroid use for less or equal to 5 days for another reason such as asthma is permissible.
•d) Severe eczema requiring regular use of potent topical steroids
•e) Family unable to comply with study requirements as judged by the investigator, such as the desire to use other non-study eczema medications unless medically indicated
•f) Use of potent topical steroids within one month of enrolment (e.g. mometasone, betamethasone, fluticasone, clobetasol)

发起方